BioGrammatics

BioGrammatics is a specialized synthetic biology CRO leveraging proprietary Pichia pastoris protein expression technology. Its business model is dual-faceted, providing both off-the-shelf research tools (vectors, strains, media) and comprehensive end-to-end protein expression services, from gene optimization to regulatory support. The company has demonstrated its platform's versatility through contributions to diverse projects, from therapeutic HIV inhibitors to food industry flavorings. As a privately held entity, it operates in the high-growth biologics and synthetic biology markets by enabling efficient, scalable protein production.

Proprietary Pichia pastoris protein expression system, including GlycoSwitch technology for humanized glycosylation, strain engineering, vector design, and associated services for gene optimization and genomic analysis.

Competes with large, full-service CROs (e.g., Lonza, Sartorius) that offer Pichia among many platforms, and life science tools companies (e.g., Thermo Fisher) selling molecular biology reagents. Differentiation is achieved through deep, exclusive focus on Pichia, proprietary glycoengineering tools (GlycoSwitch), and personalized customer support for both DIY and full-service clients.